Testimonials From Understanding Pharma Market Access & Payers in Europe
Very comprehensive overview of the payer landscape in Europe - I would highly recommend!
Osprey Health ConsultingPeirce Treacy, Strategic Consultant - United Kingdom - March 2023 (live online course)
Extremely clear and engaging course. I'll happily recommend it to my colleagues who are also very much interested in grasping general concepts of market access. Thanks to Nick and also to CELforPharma for their kind support throughout the day.
NovartisAnna Jedrusik, Senior Manager, Public Affairs, Region Europe - Switzerland - December 2022 (live online course)
Good time with excellent overview of reimbursement systems in EU5.
NutriciaArtur Krzyżanowski, Medical Affairs & Market Access Director - Poland - December 2022 (live online course)
Very relevant and engaging course by Nick Proctor - I can highly recommend the course to HEOR and Access professionals working in global roles.
Novo NordiskSara Larsen, Senior Global HEOR Manager - Denmark - October 2022 (live online course)
Nick gave a very relevant overview of what matters to payers across Europe. Very intense and insightful!
BiotestJonas Alfermann, Head of Market and Pricing Insights - Germany - October 2022 (live online course)
Everything you always wanted to know about market access strategies (but were afraid to ask) can be found in Nick's great course!
EFPIAFrançois Bouvy, Executive Director Economic and Social Affairs - Belgium - March 2022 (live online course)
I now have a better understanding of what market access really is thanks to Nick’s clarifications of terms and definitions on what is a very complex topic. I know now what the dynamics and differences between countries are. I loved having such a diverse group on the course to also get their input from their countries. Thank you.
Dr. SchärMelanie Steinmair, Medical Affairs Manager Renal Nutrition - Italy - March 2022 (live online course)
The course is an excellent option to learn about the access function in one day from a company perspective, as well as the behaviours of the different decision maker archetypes that drive decisions in access to medicines in Europe.
Vertex PharmaceuticalsFernando Albertos Martínez, International Pricing and Market Access Associate Director - Spain - March 2022 (live online course)
Excellent course for anybody looking to get an introduction into market access pathways in the EU5 countries.
EFPIAMihai Rotaru, Senior Manager, Market Access - Belgium - March 2022 (live online course)
A very well put together course by Nick to give an overview of EU market access in just 1 day. This cannot be easy as there is plenty to learn and talk about! It is broken down with enough detail but not too much that it distracts from the bigger picture and the variation of MA landscapes.
InsmedJoe Willard, Associate Director MA UK&I - United Kingdom - March 2022 (live online course)
Fantastic introduction - highly appreciated for a 'newbie'.
EFPIASophie Millar, Public Affairs Manager - Belgium - March 2022 (live online course)
I came away from the course with an excellent overview of Market Access in pharma. Nick demonstrated a rather deep knowledge of all topics covered during the training and I gained lots of valuable insights condensed into 1 day. Also, excellent organisation and communication by CELforPharma. Many thanks.
BayerJens Scheidtmann, Lead Data Architect Market Access - Germany - December 2021 (live online course)
This course provides a very good overview of the market access landscape and players in Europe. Nick is definitely an expert in his field and did a great job presenting. We got enough opportunities to interact with the other participants, which provided a variety of different perspectives due to our different backgrounds. Thanks.
SantenNadiya Deferne, Public Affairs Lead - Switzerland - December 2021 (live online course)
Nick really added great value to the day by giving us a detailed look at the key European market access processes as well as a good insight into the cross-functional process for optimal access. He is a very good speaker and engaging presenter with extensive knowledge used to answer any and all questions. The CELforPharma staff were incredibly helpful and very much on top of everything. Thank you both so much!
Novo NordiskYannick Van Ballaer, Project Manager - Switzerland - October 2021 (live online course)
Nick was very good at explaining everything and gave us a nice general overview of the Market Access process in Europe. The content was perfectly aligned with my expectations. Thanks to both Nick and CELforPharma!
BluepharmaAna Patricia Rei, Head of Portfolio Management - Portugal - October 2021 (live online course)
Nick has real experience which added lots of value to the course because it meant he was able to give us concrete details and examples on major markets. He really did a great job presenting. Thank you. I would like to also say thank you for the service from CELforPharma which was indeed excellent before, during and after the course.
TecnimedeMiguel Ruas Da Silva, Vice-President - Portugal - October 2021 (live online course)
Very good course, delivered by a knowledgeable expert.
YakumedMohamed Oubihi, CEO - United Kingdom - October 2021 (live online course)
The expert trainer Nick gives you a good insight into the possible difficulties of successful market access in different countries and what to keep in mind to avoid those difficulties as much as possible. I want to thank Nick for a great training and thank CELforPharma for being so helpful to make sure I was set and ready to attend and ensure all ran smoothly on the day.
AOP OrphanSimone Klingenbrunner, Business Development Specialist - Austria - October 2021 (live online course)
The course gave a nicely detailed coverage of the different MA approaches across Europe with an excellent and knowledgeable presenter. Thanks to Nick and the CELforPharma team. It was a very enjoyable course day!
TakedaSam Williams, Tender & Pricing Manager - United Kingdom - June 2021 (live online course)
Having transitioned from an affiliate to a global role, this was the type of EU5 country-comparisons and discussions I was looking for. The content and the moderation enables detection of patterns regarding key new developments between countries. One of my favourite aspects was the interactive group discussions, polls and quizzes. A good group and enjoyable course. Thank you.
FerringSebastian Vosgerau, Associate Dir. Global Market Access & Strategic Pricing - Germany - June 2021 (live online course)
For those who wish to be initiated to Market Access, I highly recommend this course. It is clear, well delivered, allows great interaction and is well organised.
argenxAdeline Boucher, Head of EU Regulatory - Belgium - June 2021 (live online course)
Great overview for a quite complex topic, in just one day.
JanssenMohamed Mokhtar, Marketing Lead Gastro - Germany - June 2021 (live online course)
Nick was a very considerate trainer, who took a complex multi-dimensional topic to a simple level, which was straightforward to understand. It helped establish a base line level of understanding of the key concepts in Market Access and Payer negotiations across Europe. Thank you.
BMSEmma Bowden, Head of Corporate Affairs, EU Cluster - United Kingdom - March 2021 (live online course)
The course was very well organised. During the course I experienced a nice atmosphere, in which I could ask any question. The expert really knows what he is talking about and was able to answer all our questions in an even more than sufficient way.
BayerFabian Deck, Solution Engineer for Market Access - Germany - March 2021 (live online course)
It was a great session, very well organised! The expert instructor navigates successfully - in a simple and clear way - the reasons for increasing payer control mechanisms across EU and their emerging needs.
UCBPanagiotis Fournaros, Market Access Performance Excellence Lead - Greece - March 2021 (live online course)
An excellent introduction to the intricacies and considerations of market access. Particularly good at highlighting the cross-functional requirement for successful market access. A good introductory course for those entering into the field or a refresher to those with experience needing an update.
KowaRod Coombs, President & Director - United Kingdom - March 2021 (live online course)
I really enjoyed Nick as a presenter and his knowledge. He had a very humorous way of portraying the info and answering the questions.
BayerSarah Koytcheva, PI2 Pricing Manager - Germany - March 2021 (live online course)
Knowledgeable presenter and well organised course. Good clear content presented.
Kyowa KirinAdam Higginson, Senior International Business Analyst - United Kingdom - December 2020 (live online course)
I truly enjoyed this course. The virtual setup worked very well. It was clear and easy to understand the course content, and I would especially recommend it to new colleagues or graduates to get a good introduction to market access and payers. I was very happy with Nick as instructor. He is very kind, engaging and communicated in an easily understandable way.
Novo NordiskCecilie Olivia Andersen, Global Payer Evidence Manager - Denmark - December 2020 (live online course)
The content met my expectations. This course gives you a good intro to market access and payers in EU - excellent for starters. Thanks also for the excellent organisation.
ArgenxStéphanie Dincq, Program Leader Drug Development - Belgium - December 2020 (live online course)
Very informative and covering relevant markets. By participating in this course, you get clarity on what Market Access is, great insight on country processes and a good understanding of the roles and responsibilities of payer archetypes.
Vertex PharmaceuticalsJames Lloyd, Associate Director Strategic Sourcing - United Kingdom - October 2020 (live online course)
I appreciated the ability to deep-dive on country-specific value assessment frameworks. I highly valued the interactivity and the trainer’s expertise. What I learned was immediately applicable to my daily work. It all worked quite well for a digital setting. Thank you, it was a valuable day!
UCBMarie Blanchard, Payer Value Strategy Lead - Belgium - October 2020 (live online course)
This is THE opportunity to learn about Market Access from an expert and to learn more about the payer archetypes. The interaction with the other participants was good and facilitated well. I also liked the use of the online voting options which made the course more engaging and interactive.
Vertex PharmaceuticalsMichael Griffin, Medical Affairs Director - United Kingdom - October 2020 (live online course)
It’s a great course to get acquainted with market access and payer archetypes in the EU. I also highly valued the sharing of examples, experiences and questions from other delegates.
Nordic PharmaSophie Van Tomme, Director Product Development - The Netherlands - October 2020 (live online course)
Very balanced training: a maximum of fundamental information without unnecessary details.
Clovis OncologyChristophe Tournay, Medical Advisor - France - December 2019 (face-to-face course)
Great training, lots of insights, appreciated there was always time for questions, complementing the presentations and interactions. Recommended for everyone who wants to get market access understanding.
SandozMaja Natek, Global Medical Manager Oncology - Germany - December 2019 (face-to-face course)
A very good overview of the country systems and other aspects that I had less insights on (hospital / retail funding, how to develop access plans). Very good for people planning a transition to market access or simply curious to know more to facilitate cross-functional collaboration.
CelgeneSilviu Popa, Associate Director, Government Relations, CEE & MENA - Belgium - December 2019 (face-to-face course)
A very useful course. Well-delivered, with extremely relevant content.
AllerganDina Anderson, Global Director, Toxin Science, Medical Affairs - United Kingdom - September 2019 (face-to-face course)
Relevant and up-to-date content, great presenters!
Chameleon Communications InternationalChiara Triulzi, Principal Writer, Medical & Commercial - United Kingdom - September 2019 (face-to-face course)
Concise, focused course, really valuable to get an overview of the Market Access framework in EU5 with examples from real life.
Merck Sharp & DohmeAikaterini Spyratou, Associate Director Marketing - Switzerland - June 2019 (face-to-face course)
A very valuable course, a good basis to start with market access.
SanofiAurore Lucas Ribon, Customer Engagement & Channel Manager GEM Switzerland - Switzerland - June 2019 (face-to-face course)
Great entry course for MA environment in EU. Practical and informative!
IpsenJace Huang, Global Marketing Director - France - June 2019 (face-to-face course)
Very good structure, clear, consistent information, well prepared trainers. Thank you!
Bristol Myers-SquibbAlina Trandafir, Access Operational Lead - Romania - December 2018 (face-to-face course)
Great module! Good examples given, not just theory. The module is clear with good lecture notes.
Novo NordiskCsilla Wolf-Ypeij, Sr. Manager Strategic Supply Chain - Switzerland - December 2018 (face-to-face course)
Great course and presenters. Really enjoyed the content and discussion. Definitely a must for understanding/introduction to Market Access. Would be good to see follow on course.
AstellasShirley Radforth, Director Pricing and Contracting - United Kingdom - December 2018 (face-to-face course)
Congrats for the training course! I have to say that the course was customized to my needs and gave me a lot of knowledge and new ideas. Met all my objectives.
Bristol Myers-SquibbViorel Constantin Vacaru, Healthcare Access Manager - Romania - December 2018 (face-to-face course)
Excellent program, comprehensive overview, exactly what I hoped for.
Reata PharmaceuticalsDawn Bir, Chief Commercial Officer - USA - September 2018 (face-to-face course)
Mark and Nick are seasoned professionals both in the industry and in leading this well executed course. Not only informative but learnings are wide reaching across a pharma consultancy field.
BresMed Health SolutionsNikki Mason, Senior Insight Analyst - United Kingdom - September 2018 (face-to-face course)
An excellent way to learn the fundamentals of Market Access.
GileadTeresa Polónio, Acting Country Counsel and Head of Legal & Business Conduct - Portugal - September 2018 (face-to-face course)
Great overview of Market Access principles in Europe!
Ipsen PharmaJan Swiderski, Public Affairs Manager - France - June 2018 (face-to-face course)
Many thanks to Nick, Mark and Sarah for the great, exciting and interesting two-day course.
AbbottSergey Yagubov, Market Access Manager - Russia - June 2018 (face-to-face course)
Great course to step into Payer's shoes. Very practical case studies and explanations of local approaches.
Purman ConsultingGabor Purman, Behavioral Economist - The Netherlands - June 2018 (face-to-face course)
Great course! Really good introduction to Market Access. Would recommend this to anyone looking to understand the fundamentals of Market Access.
GSKFrances Jenkins, Market Access and Medicines Vision - United Kingdom - December 2017 (face-to-face course)
Great course! Really valuable and practical information about the world of payers, delivered by professionals. I’d highly recommend it to everyone involved in market access.
Accord HealthcareOlga Diachenko, Market Access Manager Europe - Czech Republic - October 2017 (face-to-face course)
Thank you for 2 perfect days with a lot of useful information.
Yuria PharmaIryna Rozhnovska, Business Development Manager - Ukraine - October 2017 (face-to-face course)
Professional experts and organizers. The course was very beneficial and very informative.
JulpharMohamed Adel Hegazi, Market Access Manager - United Arab Emirates - October 2017 (face-to-face course)
Very useful training, I've improved my understanding of national systems in Europe. Also, I've strengthened my knowledge of general aspects of market access. I will recommend this training to my colleagues.
TakedaBozena Drewicz, Sr. Director, Market Access and Preparedness, The Americas - Switzerland - May 2017 (face-to-face course)
Very informative course, would recommend to anyone who wants to learn more about market access.
GlobalDataElizabeth Hamson, Healthcare Analyst - United Kingdom - May 2017 (face-to-face course)
Another great course giving valuable insights into the A-Z of Market Access – with top experts delivering complex information in easily understandable chunks.
AstellasLorraine Tweddle, Associate Brand Director - United Kingdom - May 2017 (face-to-face course)
Learning and discussing market access with international experts like Mark and Nick really helps you in building future strategy that best responds to the demands of changing healthcare systems.
Bristol-Myers SquibbCatalina Moinescu, Customer Marketing Manager Virology - Romania - December 2016 (face-to-face course)
Great course! Nice to be a part of it and learn from 2 specialists with loads of insights and advice. The group work on developing a Market Access Plan was SUPER!
MundipharmaChristiane Bullmann, Medical Affairs Manager - United Kingdom - December 2016 (face-to-face course)
High quality course in terms of both content and practical arrangements. I also highly valued the interaction between participants. Thank you!
UCBJérémy Peaudecerf, Operational Excellence Project Manager - Belgium - December 2016 (face-to-face course)
This was a great educational experience. I gained a lot of new insights and useful information – Highly recommendable!
AstraZenecaNikolina Škaron, Market Access, Pricing & Government Affairs Manager - Croatia - December 2016 (face-to-face course)
Excellent course describing Market Access fundamentals for the EU5 – Highly recommended!
Receptos (Celgene)Daniel Cole, Director Market Access - United States - September 2016 (face-to-face course)
Thank you – very useful! I feel more confident now :)
Novo NordiskRebecca Currie, Senior Global Public Affairs Manager - Denmark - September 2016 (face-to-face course)
An excellent course giving a thorough EU5 view on Market Access systems and valuable tools and frameworks to easily apply to my current and/or future projects!
NorgineVasudha Bajaj, Senior Global Business Intelligence Analyst - United Kingdom - September 2016 (face-to-face course)
I really enjoyed this C.E.L.forpharma course and gained a lot: I now have a good overview of Market Access and am able to compare healthcare systems and apply that to non-EU5 countries – exactly what I needed!
Integro PharmacyDavid Hammond, Commercial Director - United Kingdom - June 2016 (face-to-face course)
Mark Silvey and Nick Proctor are very experienced. Their course provides a comprehensive overview of Europe’s major markets and offers many insights as well as good discussions – highly recommendable!
AstellasDr. Anne-Katrin Neumann, Senior Manager Market Access - Switzerland - June 2016 (face-to-face course)
C.E.L.forpharma’s Market Access course answered all of my questions and filled a lot of the gaps I had! Everything was extremely interesting and useful - I really learnt a lot!
AmgenOlivia McDermid, Project Manager - Value Based Healthcare - Switzerland - June 2016 (face-to-face course)
I greatly appreciate this thorough introduction to market access, given by enthusiastic expert speakers in the field.
Xellia PharmaceuticalsBeate Rygg Johnsen, Portfolio Manager - Norway - December 2015 (face-to-face course)
A great professional "duo" driving us through the world of payers in the EU.
NovartisChristophe Gerbeau, Head Market Access Early Products - France - December 2015 (face-to-face course)
As someone who is keenly interested in a more holistic approach to drug development and commercialisation, I found the course to be very useful in providing both a broad context as well as sufficient detail to understand successful strategies for developing and implementing an effective market access plan.
BiogenDr. Vijaya Raman-Chandra, Sr. Director & Head Global Medical Writing - United States - December 2015 (face-to-face course)
Useful course, good experts and amazing organisation!
LillyFernando Granell, Payer Strategy Manager - Spain - December 2015 (face-to-face course)
It's been a pleasure being able to participate in this training. Nick & Mark, you make difficult things easy: It's been great learning with & from you!
LillyMónica Chaler Milián, Corporate Affairs - Spain - December 2015 (face-to-face course)
I'm very impressed by the extensive knowledge and expertise of the trainers. Receiving relevant information in an overview form was important for me. I recommend this course, as all I needed was given.
CSL BehringAlexander Wilke, Director Health Care Policy & External Affairs - Germany - September 2015 (face-to-face course)
Very good and comprehensive overview of what Market Access means and embraces. Rich and interactive course, greatly balancing concepts, real pharma cases and exercises. Thank you!
SanofiRoselyne Beaux, Project Director Operations, Global Market Access - France - September 2015 (face-to-face course)
Both Lloyd and Nick have extensive knowledge of the Market Access principles and the diversified environment in the EU. They delivered an excellent course full of real life examples.
PfizerYannis Apostolakis, Senior Brand Manager - France - September 2015 (face-to-face course)
I personally attended the Market Access course and many other Chiesi employees participated in other courses ... with the same output … great attendance and great value!
ChiesiUgo Bettini, Corporate Head Human Resources & Organization - Italy - August 2015 (face-to-face course)
Really valuable insights into differences but also similarities between key markets, their processes and stakeholder needs. Thanks!
TevaJelle Kleijn, Market Access Lead OncoCare & Womens Health Europe - The Netherlands - May 2015 (face-to-face course)
This course helped me to better understand Market Access principles, which in turn enables me to give more precise strategic consulting to our customers.
Veeva SystemsRoland Seibt, Senior Consultant KOL Solutions - Germany - May 2015 (face-to-face course)
This was one of the best courses I've taken in the field of executive education. Both instructors are very knowledgeable, patient and have a wicked sense of humor. I highly recommend it!
Novo NordiskAnirvan Dutt-Chaudhuri, Global Product Manager - Switzerland - December 2014 (face-to-face course)
Excellent content and fantastic delivery. Good balance between 'academic' information and exercises. Thank you!
Bristol-Myers SquibbAnne Vandevoorde, Director Customer Insight & Analytics Europe - France - December 2014 (face-to-face course)
Very useful and practical training! Every marketer at every level should take it!
ShireEva Panarese, Associate International Product Director - Belgium - December 2014 (face-to-face course)
Thank you very much, this Market Access course is very helpful!
ShireNicole, Global Marketing - Switzerland - October 2014 (face-to-face course)
This course not only has a diverse audience, you also benefit from good interactions with other participants.
GenzymeRegine Buffels, Director Medical Affairs MS EMEA - Switzerland - October 2014 (face-to-face course)
Excellent overview! Both speakers have a high level of expertise and share up-to-date information during the 2 days. Really great!
ServierElena Liliana Louette, Training Manager - France - May 2014 (face-to-face course)
A good overview and introduction to the MA systems in Big-5! Lloyd and Mark were very knowledgeable and gave great examples.
SOBIBodil Jonason, Executive Director Global Marketing - Sweden - September 2013 (face-to-face course)
The training was very well built-up and gives a lot of insight into the world of the payers and how they are thinking. It was very useful!
ThromboGenicsCaroline van Mol, Project Coordinator Market Access - Belgium - September 2013 (face-to-face course)
Possibly the ultimate shortcut to get a basic understanding of Market Access in the EU5 without being just an academic exercise.
JNB McCann HealthcareChristopher Funk, Director Strategic Planning - Germany - September 2013 (face-to-face course)
Excellent course to get an overview on Market Access in Europe. Good concept to have 2 speakers (real experts) and to switch after a set of presentations.
RocheManfred Mülchi, Health Care Affairs Manager - Switzerland - June 2013 (face-to-face course)
A very well planned course with the right mix of lecturing and interaction. The expertise of Lloyd and Mark transforms very well.
Molecule ConsultancyMette Sorensen, Managing Director - Denmark - June 2013 (face-to-face course)
A top line overview enriched with interactive, real life discussions with true experts leading to valuable take home thoughts. Looking forward to my next CELforpharma course.
TillottsSandra Haas, Product Manager - Switzerland - June 2013 (face-to-face course)
Very good introduction course of Pharma Market Access in Europe, very complete information. Huge, useful docs to be reviewed at home, which is really great.